Compassionate Certification Centers is proud to announce the initiation and incorporation of our Clinical Research Division.
Led by Chief Medical Officer Dr. Bryan Doner and Chief Research Officer Dr. Keyur Patel, the research division at CCC was initiated to help better patient care and product development while providing clinical insight for the ever-changing landscape of medical cannabis related therapies.
With extensive clinical research experience, over 10 brick and mortar locations, approximately 20 physicians, and over 50,000 patients to date, Compassionate Certification Centers offers the personnel, experience, and capabilities to initiate and manage clinical research trials on a large-scale and ongoing basis
Our physician leaders, Dr. Doner and Dr. Patel, have combined over 20 years clinical research experience serving as Primary and Sub-Investigators in multiple FDA sanctioned and approved clinical trials. In addition to our physician support, CCC has dedicated internal Clinical Research Coordinators and collaborative Clinical Research Organizations (CRO), ensuring the capacity to effectively conduct clinical research trials in a timely and cost-effective manner.
Are you a patient interested in participating in a Clinical Research Trial? Do you have a product that requires clinical research and testing? If so, please contact Compassionate Certification Centers and somebody from our Research Division will contact you to discuss further.
Compassionate Certification Centers works in partnership with D&P Medical Group to organize and participate in clinical research opportunities involving medical cannabis and CBD. D&P Medical Group provides client-based services in the fields of wound care, hyperbaric medicine, medical cannabis, clinical research, and product development. Our services include state of the art patient evaluation and treatment, clinical research, product testing and development, consulting/advisor services, clinical staffing, and educational related services.
Affinity Bio Partners (ABP) and its affiliates ensure that on a global basis that clinical research is performed safely, ethically, with high-quality so that subjects can benefit from the development of new and novel treatments and therapies. ABP represents the world’s leading cutting-edge Clinical Research Organization (CRO) – recently announcing participation in groundbreaking Medical Marijuana and Cannabinoid Clinical Research activities. Affinity Bio Partners LLC endeavors to provide integral enterprise-wide solutions that facilitate the development of drugs, biologics, natraceuticals and medical devices.
AI Health Outcomes was launched to introduce the Cannabot™ – a unique AI Bot that helps patients connect with MJJ physicians and dispensaries. CannaBot™ is available as a published skill on Alexa and published Action on Google. CannaBot™ works on Skype and helps in Clinical Research with better patient compliance.
Observational Retrospective Data Analysis
Pennsylvania Medical Marijuana Program – Year 1
IBS and CBD
A Randomized, Placebo Controlled Double-Blind Proof of Concept study to evaluate safety, tolerability and preliminary efficacy of a botanical Cannabidiol (CBD) Extract for patients with Irritable Bowel Syndrome (IBS)
Chronic Musculoskeletal & Neuropathic Pain and CBD
An Observational Proof of Concept Study to demonstrate the Safety and Efficacy of Pharmaceutical grade CBD in Male and Female Subjects with Chronic Musculoskeletal and Neuropathic Pain
Upcoming Research Projects
Oral CBD and its effects on Post-Concussion Syndrome & Topical CBD and its effects on wound healing properties
June 25, 2019
Compassionate Certification Centers™, a medical cannabis healthcare network, in collaboration with Affinity Bio Partners, a Clinical Research Organization (CRO) and AI Health Outcomes, CannaBot™, is pleased to announce the initiation of a medical marijuana focused observational study in Pennsylvania.
June 13, 2019
A shift from brain systems controlling reward-driven use to habit-driven use differentiates heavy cannabis users who are addicted to the drug from users who aren’t, according to a new study. The findings help explain how the brain becomes dependent on cannabis, and why not all cannabis users develop an addiction, even with long-term regular use.
June 10, 2019
Legalizing medical marijuana does not reduce the rate of fatal opioid overdoses, according to researchers.
March 22, 2019
A new study based on a mostly forgotten guide to medicinal plants, ‘Resources of the Southern Fields and Forests,’ focuses on three of the plants and shows they inhibit bacteria associated with wound infections.
February 11, 2019
Compassionate Certification Centers, a medical cannabis healthcare network in Pennsylvania, is currently leading the first clinical research study on Irritable Bowel Syndrome and CBD.